Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
J Immunol. 2024 Oct 15;213(8):1093-1104. doi: 10.4049/jimmunol.2300842.
We developed a linear amplification-mediated high-throughput genome-wide translocation sequencing method to profile Ig class-switch recombination (CSR) in human B cells in an unbiased and quantitative manner. This enables us to characterize CSR junctions resulting from either deletional recombination or inversion for each Ig class/subclass. Our data showed that more than 90% of CSR junctions detected in peripheral blood in healthy control subjects were due to deletional recombination. We further identified two major CSR junction signatures/patterns in human B cells. Signature 1 consists of recombination junctions resulting from both IgG and IgA switching, with a dominance of Sµ-Sγ junctions (72%) and deletional recombination (87%). Signature 2 is contributed mainly by Sµ-Sα junctions (96%), and these junctions were almost all due to deletional recombination (99%) and were characterized by longer microhomologies. CSR junctions identified in healthy individuals can be assigned to both signatures but with a dominance of signature 1, whereas almost all CSR junctions found in patients with defects in DNA-PKcs or Artemis, two classical nonhomologous end joining (c-NHEJ) factors, align with signature 2. Thus, signature 1 may represent c-NHEJ activity during CSR, whereas signature 2 is associated with microhomology-mediated alternative end joining in the absence of the studied c-NHEJ factors. Our findings suggest that in human B cells, the efficiency of the c-NHEJ machinery and the features of switch regions are crucial for the regulation of CSR orientation. Finally, our high-throughput method can also be applied to study the mechanism of rare types of recombination, such as switching to IgD and locus suicide switching.
我们开发了一种线性扩增介导的高通量全基因组易位测序方法,以非偏见和定量的方式描绘人类 B 细胞中的 Ig 类转换重组 (CSR)。这使我们能够描述每种 Ig 类/亚类的缺失重组或反转产生的 CSR 连接。我们的数据表明,在健康对照个体的外周血中检测到的超过 90%的 CSR 连接是由于缺失重组。我们进一步鉴定了人类 B 细胞中的两种主要 CSR 连接特征/模式。特征 1 由 IgG 和 IgA 转换产生的重组连接组成,Sµ-Sγ 连接占主导地位 (72%),且缺失重组占主导地位 (87%)。特征 2 主要由 Sµ-Sα 连接组成 (96%),这些连接几乎都是由于缺失重组 (99%),并且具有更长的微同源性特征。在健康个体中鉴定的 CSR 连接可以归属于这两个特征,但以特征 1 为主,而在 DNA-PKcs 或 Artemis 缺陷患者中发现的几乎所有 CSR 连接,这两个都是经典的非同源末端连接 (c-NHEJ) 因子,与特征 2 一致。因此,特征 1 可能代表 CSR 过程中的 c-NHEJ 活性,而特征 2 与缺乏研究的 c-NHEJ 因子时的微同源介导的替代末端连接相关。我们的发现表明,在人类 B 细胞中,c-NHEJ 机制的效率和开关区的特征对于 CSR 定向的调控至关重要。最后,我们的高通量方法也可应用于研究罕见类型重组(如 IgD 转换和基因座自杀转换)的机制。